Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast cancers can recur years after treatment, with the aim of identifying patients at greatest risk. Around 80% of breast cancers in the UK are ER-positive. Although many patients do not experience a recurrence, some cancer […]
The post Charity commits £800,000 to AI research into late breast cancer recurrence appeared first on Pharmafile.